CNO Financial Gr (NYSE:CNO) reported quarterly earnings of $0.49 per share which met the analyst consensus estimate. This is a 31.94 percent decrease over earnings of $0.72 per share from the same period last year. The company reported quarterly sales of $905.30 million which beat the analyst consensus estimate of $893.79 million by 1.29 percent. This is a 6.51 percent decrease over sales of $968.30 million the same period last year.
Related Posts
Global Markets Today While US Was Sleeping
On Monday, July 24, the U.S. markets ended in green, with Dow Jones continuing its winning streak for the eleventh day, ahead of a week filled with earnings reports and a Federal Reserve meeting.
The Dow Jones Industrial Average closed higher by 0.52% at 35,411.24 on Monday; the S&P 500 closed 0.40% higher at 4,554.64; and the Nasdaq Composite rose 0.19% to 14,058.87.
Unlocking Xenon Pharmaceuticals $1B Potential: Analyst Cites Anti-Epileptic Candidate’s Untapped Value
Cantor Fitzgerald has initiated coverage on Xenon Pharmaceuticals Inc (NASDAQ: XENE) with an Overweight rating and a
Reported Late Monday, NeoGenomics Announces Jeffrey S. Sherman Will Join The Company As Chief Financial Officer Effective December 7, Succeeding William Bonello Who Will Remain With The Company To Provide Transition And Onboarding Support For A Period…
Jeffrey S. Sherman Appointed Chief Financial Officer